314 stories tagged ‘Brigham and Women’s Hospital’
Researchers from Harvard-affiliated Brigham and Women’s Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors.
Two Harvard Stem Cell Institute researchers have identified a protein in the blood of mice and humans that may prove to be the first effective treatment for the form of age-related heart failure that affects millions of Americans, a study says.
Members of the Harvard community responded to the Boston Marathon attacks and offered thoughts about both the physical and mental injuries they caused.
Environment counts, Alzheimer’s research suggests
A new study led by Harvard Medical School Professor Dennis Selkoe provides specific, pre-clinical scientific evidence supporting the concept that prolonged and intensive stimulation by an enriched environment may have beneficial effects in delaying one of the key negative factors in Alzheimer’s disease.
HMS partners with NFL Players Association
he National Football League Players Association (NFLPA) has awarded Harvard Medical School a $100 million grant to create a transformative 10-year initiative — Harvard Integrated Program to Protect and Improve the Health of NFLPA Members.
Checklists in operating rooms improve performance during crises
In an airplane crisis—an engine failure, a fire—pilots pull out a checklist to help with their decision-making. But in an operating room crisis—massive bleeding, a patient’s heart stops—surgical teams don’t. Given the complexity of judgment and circumstances, standard practice is for teams to use memory alone. In a new study published in the January 17 [...]
Researchers from Harvard-affiliated Brigham and Women’s Hospital have found that some patients who receive generic drugs that vary in their color are over 50 percent more likely to stop taking the drug, leading to potentially important and potentially adverse clinical effects.
In a study from Harvard-affiliated Brigham and Women’s Hospital, researchers used a novel method to identify the new heart cells and describe their origins.
‘Stem cell tourism’ growing trend
A Harvard panel examined the problem of clinics around the world that provide stem cell treatments for intractable conditions. Although there is no medical evidence of the treatments’ effectiveness, such clinics have drawn thousands of patients from many countries.
Joseph E. Murray, emeritus professor of surgery at Harvard Medical School, whose many breakthroughs included the first successful kidney transplant, died Nov. 26, after suffering a hemorrhagic stroke at his Wellesley, Mass., home on Thanksgiving. He was 93.
Researchers designed a chip that uses a 3-D DNA network made up of long DNA strands with repetitive sequences that — like the jellyfish tentacles — can detect, bind, and capture certain molecules.
Researchers have found that a protozoan parasite causing an STD that affects a quarter of a million people yearly is fueled in part by its own viral symbiont. Antibiotics that simply kill the parasite are not the solution.
“We found that adding low amounts of physical activity to one’s daily routine, such as 75 minutes of brisk walking per week, was associated with increased longevity: a gain of 1.8 years of life expectancy after age 40, compared with doing no such activity,” explained Harvard Medical School Professor of Medicine I-Min Lee.
Probing sleep’s drowsy mystery
Harvard researchers have worked for years to understand better the familiar mystery of sleep, highlighting not only what happens when we close our eyes, but also the effects on us when we don’t.
Aspirin’s impact on colorectal cancer
Harvard researchers at Dana-Farber Cancer Institute find that aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but it has no effect on patients who lack the mutation.
Skin cancer detection breakthrough
Researchers at Harvard-affiliated Brigham and Women’s Hospital have pinpointed when seemingly innocuous skin pigment cells mutate into melanoma.
Pain relievers increase hearing loss risk
According to a study by researchers at Harvard-affiliated Brigham and Women’s Hospital, women who took ibuprofen or acetaminophen two or more days per week had an increased risk of hearing loss.
Women pay high price for high job strain
New research from Brigham and Women’s Hospital (BWH) finds that women with high job strain are more likely to experience a cardiovascular-related event compared with women with low job strain. These findings are published in the open access journal PLoS ONE.
Clot-busting technology goes straight to work
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or even death.
Heart attack worsens atherosclerosis
Researchers at Harvard Medical School and Harvard-affiliated Massachusetts General Hospital have found that the body’s immune response to heart attacks actually worsens atherosclerosis, increasing future heart attack risk, according to a study published in the journal Nature.
Brigham team implants artificial heart
The first complete artificial heart transplant in New England was performed at Harvard-affiliated Brigham and Women’s Hospital.
Exercise reduces psoriasis risk
A study by researchers at Harvard-affiliated Brigham and Women’s Hospital adds to the list of medical problems that exercise eases, showing that vigorous activity reduces a woman’s risk of developing the skin condition psoriasis by 25 to 30 percent over the study subject who exercised the least.
Thinking about health as an investor might
A “proof-of-concept” study that applies financial portfolio theory to federal life science research funding shows that potentially significant gains are available by altering the allocation of funding by the National Institutes of Health.
A new study by Harvard researchers at Brigham and Women’s Hospital (BWH) finds that a high intake of flavonoid-rich berries, such as strawberries and blueberries, over time, can delay memory decline in older women by two and a half years.
Insight on triple-negative breast cancer
Scientists from Harvard-affiliated Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive “triple-negative” breast cancers and certain ovarian cancers are likely to respond to platinum-based chemotherapies.
Cloudy, 55° F